Jeffrey Triganza Joins Vantage Markets Australia as Head of Market Analysis

---
Jeffrey Triganza Joins Vantage Markets Australia as Head of Market Analysis
Vote:
0 0
Previous US FDA Grants Orphan Drug Designation of SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung Cancer
Next JSAUX'S STEAM DECK RGB DOCKING STATION & RGB BACKPLATE ARE NOW AVAILABLE

Related News

Vantage Markets appoints new Head of Sales for Australia

Vantage clinches 11 new awards in 2023 from ForexBrokers.com and Ultimate Fintech.

Vantage awarded Best APAC Region Broker at ADVFN International Awards 2023

Vantage Gains FSCA License to Operate in South Africa

Vantage Unveils Loyalty Programme to Make Trading More Rewarding for Clients

Vantage's swap-free trading provides gold traders nearly US$1million in savings over a three-month period

menu
menu